Thursday, 21 November 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 21 November 2024
News

Who's trying to dethrone Keytruda?

Posted 20 November 2024 AM

It's the highest selling drug in the world but MSD's Keytruda had better watch out with moves underway by rivals to steal the immunotherapy's crown.

BioNTech is the latest company to claim it has found "the next-generation immune modulator",  announcing late last week it would fork out US$800 million upfront to buyout China-based Biotheus, plus up to US$150 million in milestone payments.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (15)

Clinical & Medical, R&D (8)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.